Jessica S. Donington, MD, on Treating Early-Stage Thoracic Cancers

Posted: Tuesday, March 19, 2019

Jessica S. Donington, MD, of the University of Chicago, discusses the role of adjuvant or neoadjuvant therapy for early-stage thoracic tumors and the currently available or investigational classes of agents that are most likely to be useful in these settings.